Search - tctmd.com

Displaying 1 - 20 of 140

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Conference News VIVA 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

L.A. McKeown

November 07, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Conference News ISC 2025

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

Todd Neale

February 11, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist

Todd Neale

January 15, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

Advertisement

TCTMD’s Biggest News of 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Two Trials Boost Intra-arterial Lytics After Stroke Thrombectomy

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist

TCTMD’s Biggest News of 2024: Stories, Videos, and More

TCTMD’s Top 10 Most Popular Stories for December 2024

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Little Pre- and Postmarket Testing for Most Recalled CV Devices

September 2024 Dispatch for the CV Team

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

FDA Approves Bioresorbable Scaffold for BTK Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content